NCT04124328View on ClinicalTrials.gov

Evaluation of Vein of Marshall Ethanol Infusion During Left Atrial Linear Ablation in Patients With Persistent Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

October 15, 2019

Primary Completion Date

March 1, 2021

Study Completion Date

March 1, 2021

Conditions
Atrial Fibrillation
Interventions
PROCEDURE

ALINE + VoM infusion

In patients assigned to the ALINE + VoM infusion group, extended ablation will be performed according to the ALINE criteria. Additionally, the vein of Marshall will be infused with ethanol.

PROCEDURE

ALINE only

In patients assigned to the ALINE only, extended ablation will be performed according to the ALINE criteria.

Trial Locations (1)

8000

AZ Sint-Jan Brugge-Oostende AV, Bruges

All Listed Sponsors
lead

AZ Sint-Jan AV

OTHER

NCT04124328 - Evaluation of Vein of Marshall Ethanol Infusion During Left Atrial Linear Ablation in Patients With Persistent Atrial Fibrillation | Biotech Hunter | Biotech Hunter